PharMEDium Hires Thomas W. Rasnic as Vice President, Quality, Regulatory Affairs and Research and Development

Dec 15, 2010, 16:44 ET from PharMEDium

LAKE FOREST, Ill., Dec. 15, 2010 /PRNewswire/ -- David N. Jonas, Chairman and CEO of PharMEDium Healthcare Corporation, announced that Thomas W. Rasnic has joined PharMEDium as Vice President, Quality, Regulatory Affairs and Research and Development.

Tom brings to PharMEDium broad experience from within the healthcare industry.  Most recently, he was Vice President of Quality and Regulatory Affairs at CareFusion Corporation.  Prior to that, Tom held a succession of quality and regulatory positions at Cardinal Health, Baxter Healthcare Corporation, Applied Quality Systems, and John O. Butler.  He is a Six Sigma certified engineer and is also a certified "Auditor/Lead Auditor," Registrar Accreditation Board.  He obtained his MBA at Keller Graduate School and a BS in Industrial Management from Northern Illinois University.  

"Our organization has been built with people who are dedicated and passionate in pursuit of quality and patient safety.  Tom's demonstrable leadership is a valuable addition to the PharMEDium executive team.  We look forward to his contribution in helping us fulfill our continuing commitment to place patient safety first and provide the highest quality of service," Jonas stated.

PharMEDium is the national leading provider of pharmacy sterile intravenous admixture compounding services. The PharMEDium network of state licensed and federally registered compounding facilities provides trusted solutions to hospitals throughout the United States. PharMEDium complies with all applicable state laws and FDA regulations, including USP Chapter (797), and DEA requirements.  For more information on PharMEDium, visit www.pharmedium.com.

SOURCE PharMEDium



RELATED LINKS

http://www.pharmedium.com